NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 64 filers reported holding NEOS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $189,000 | -22.2% | 38,908 | 0.0% | 0.01% | -26.7% |
| Q2 2018 | $243,000 | -39.7% | 38,908 | -19.8% | 0.02% | -48.3% |
| Q1 2018 | $403,000 | -13.5% | 48,532 | +6.1% | 0.03% | -21.6% |
| Q4 2017 | $466,000 | -45.0% | 45,721 | -50.6% | 0.04% | -51.3% |
| Q3 2017 | $847,000 | +81.0% | 92,567 | +44.3% | 0.08% | +72.7% |
| Q2 2017 | $468,000 | +108.9% | 64,157 | +105.9% | 0.04% | +109.5% |
| Q1 2017 | $224,000 | +163.5% | 31,157 | +113.6% | 0.02% | +110.0% |
| Q4 2016 | $85,000 | – | 14,587 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|